Syneron-Candela has rebranded the company to Candela and unveiled its new corporate branding at the American Academy of Dermatology (AAD) Annual Meeting. The new corporate identity reflects the unification of the Syneron and Candela brands and is designed to support continued global market growth as a unified single entity.

“Re-launching the company as Candela and aligning around its brand pillars of Science, Results and Trust, reflects our commitment to Candela’s guiding principles of safety, efficacy and reliability. It also reflects our commitment to strengthening the longstanding partnerships of trust Candela has established with physicians, their practices and the patients they treat,” says Geoffrey Crouse, Chief Executive Officer of Candela. Candela’s new brand identity went live with the launch of its new corporate website www.candelamedical.com, new marketing materials, print, digital, and social campaigns. New patient, physician, and practice focused assets will continue to be rolled out over the course of the year.

“Scientific rigor, clinical outcomes and building trusting partnerships with physicians are the same values that established Candela’s historic leadership over the years. The combination of Candela’s new management, innovation of products such as the Vbeam Prima system coupled with Candela’s values, strongly positions the company for continued growth while making them an even more trusted partner to medical aesthetic practices globally,” says Eric Bernstein, MD, an Ardmore, PA-based dermatologist who is also chairperson of Candela’s Medical Advisory Board. 

In addition to unveiling its new visual brand identity, the company also presented products and technologies highlighting clinical outcomes during 18 clinical presentations and educational courses at the AAD. Candela also showcased its newest products–the Vbeam Prima and Nordlys systems. The Vbeam Prima device is an advanced 595nm pulse dye laser (PDL). With the addition of a 1064 nm wavelength and a number of other new user focused features, the Vbeam Prima device is able to effectively treat a broad range of skin conditions, including: rosacea, port wine stains, acne, facial, leg and spider veins, scars, benign pigmented lesions and wrinkles, warts, stretch marks, and photoaging.

The Nordlys device is a multi-application, multi-technology IPL and Nd:YAG platform for vascular and pigmented lesions, as well as hair removal. The Nordlys system also offers a fractionated 1550nm handpiece for skin resurfacing. Both devices as part of the entire portfolio of Candela products will be on display at the Candela exhibit (#2137) at the 2019 AAD.